Ciglitazone

Caroline Day*, Clifford J. Bailey

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

Abstract

Ciglitazone was the first antidiabetic thiazolidinedione to be described in detail ....

Original languageEnglish
Title of host publicationxPharm
Subtitle of host publicationthe comprehensive pharmacology reference
EditorsS.J. Enna, David B. Bylund
PublisherElsevier
Number of pages2
ISBN (Print)978-0-08-055232-3
DOIs
Publication statusPublished - Feb 2011

Fingerprint Dive into the research topics of 'Ciglitazone'. Together they form a unique fingerprint.

  • Research Output

    • 6 Chapter (peer-reviewed)

    Biguanides

    Day, C. & Bailey, C. J., Feb 2011, xPharm: the comprehensive pharmacology reference. Enna, S. J. & Bylund, D. B. (eds.). Elsevier, 3 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

  • Metformin

    Day, C. & Bailey, C. J., 1 Dec 2011, xPharm: the comprehensive pharmacology reference. Enna, S. J. & Bylund, D. B. (eds.). Elsevier, 4 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

  • Pioglitazone

    Day, C. & Bailey, C. J., 1 Dec 2011, xPharm: the comprehensive pharmacology reference. Enna, S. J. & Bylund, D. B. (eds.). Elsevier, 4 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

  • Cite this

    Day, C., & Bailey, C. J. (2011). Ciglitazone. In S. J. Enna, & D. B. Bylund (Eds.), xPharm: the comprehensive pharmacology reference Elsevier. https://doi.org/10.1016/B978-008055232-3.61464-3